About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Visit our Heart Failure Management Hub to discover a range of educational content to facilitate the use of SGLT-2 inhibitors and other guideline directed medical therapies as foundational treatment for HF.

Articles

Breaking the Cycle of HFpEF and AF

Published:

18 November 2022

Citation:

Cardiac Failure Review 2022;8:e32.

Multimodality Imaging in Valvular Structural Interventions

Published:

18 November 2022

Citation:

Cardiac Failure Review 2022;8:e31.

BCIS Consensus: A Huge Step Towards Standardised Care for OHCA

Published:

10 November 2022

Citation:

Interventional Cardiology 2022;17:e17.

Immunoglobulin Free Light Chains for AF

Published:

09 November 2022

Citation:

European Cardiology Review 2022;17:e22.